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Introduction
Familial Mediterranean Fever (FMF) is an autosomal
recessive disease, characterised by recurrent, self limited
attacks of fever with serositis. The gene responsible for
FMF, designated as MEFV, encodes pyrin.
Objectives
The aim of this study was to compare the demographic
and clinical features of FMF patients with heterozygous
MEFV mutations to those with homozygous or compound
heterozygous mutations.
Methods
Files of patients who had been seen in our department
(during routine follow-up visits) between January 2013
and January 2014 were retrospectively evaluated. Six
predominant mutations (p.M694V, p.M680I, p.M694I,
p.V726A, p.K695R, p.E148Q) in the MEFV gene were
studied in our center. Patients were divided into two
groups: group I included patients with heterozygous muta-
tions and group II included patients with homozygous or
compound heterozygous mutations.
Results
The study group comprised 263 FMF patients (145
females, 118 males) with a mean age of 9.7 ±5.2 years.
There were 83 patients in group I and 180 patients in
Group II. Although age at disease onset and clinical find-
ings did not differ between the two groups, age at onset of
colchicine therapy was lower in group II (p<0,05) patients.
Family history of FMF was more frequently detected in
group II (p=0,016). Acute phase reactant levels during the
attacks before colchicine therapy and the attack-free per-
iod after colchicine therapy were higher in group II
(p<0,05). Median PRAS severity score and final colchicine
dosages were also higher in group II (p<0,05) patients.
Conclusion
As an expected finding FMF patients with homozygous
and compound heterozygous mutations have more
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